- conflicts or gaps
- [[{"topic": {"value": "Founder listing inconsistency", "source_urls": ["https://www.ycombinator.com/companies/ochre-bio", "https://hoxtonventures.com/portfolio/ochre-bio/", "https://eithealth.eu/news-article/ochre-bio-closes-e30m-series-a-funding-round/"]}, "details": {"value": "YC profile founder section shows Quin Wills twice and does not display Jack O'Meara, while other sources list both co-founders.", "source_urls": ["https://www.ycombinator.com/companies/ochre-bio", "https://hoxtonventures.com/portfolio/ochre-bio/", "https://eithealth.eu/news-article/ochre-bio-closes-e30m-series-a-funding-round/"]}}, {"topic": {"value": "Series A currency mismatch", "source_urls": ["https://eithealth.eu/news-article/ochre-bio-closes-e30m-series-a-funding-round/", "https://www.ycombinator.com/companies/ochre-bio"]}, "details": {"value": "Series A is reported as €30M by EIT Health, while YC-linked coverage headline references $30M.", "source_urls": ["https://eithealth.eu/news-article/ochre-bio-closes-e30m-series-a-funding-round/", "https://www.ycombinator.com/companies/ochre-bio"]}}, {"topic": {"value": "Employee count variance", "source_urls": ["https://www.ycombinator.com/companies/ochre-bio", "https://uk.linkedin.com/company/ochre-bio", "https://leadiq.com/c/ochre-bio/5e747adf1d6f06b3824bb58a", "https://rocketreach.co/ochre-bio-management_b437f3e9c1f376e6"]}, "details": {"value": "Reported headcount varies across sources (50, 56, 61, 62).", "source_urls": ["https://www.ycombinator.com/companies/ochre-bio", "https://uk.linkedin.com/company/ochre-bio", "https://leadiq.com/c/ochre-bio/5e747adf1d6f06b3824bb58a", "https://rocketreach.co/ochre-bio-management_b437f3e9c1f376e6"]}}, {"topic": {"value": "Total funding aggregation ambiguity", "source_urls": ["https://www.cbinsights.com/company/ochre-bio/financials", "https://www.seedtable.com/startups/Ochre_Bio-R9V9YR8", "https://tracxn.com/d/companies/ochrebio/__z2z_0KMLRlfkCrZvyOTtgnJ1eFnZwe8OCY_Kbk-RdwM"]}, "details": {"value": "Third-party trackers report different total raised amounts and round counts; direct company disclosures provide clear amounts for seed and Series A but not a canonical cumulative total.", "source_urls": ["https://www.cbinsights.com/company/ochre-bio/financials", "https://www.seedtable.com/startups/Ochre_Bio-R9V9YR8", "https://tracxn.com/d/companies/ochrebio/__z2z_0KMLRlfkCrZvyOTtgnJ1eFnZwe8OCY_Kbk-RdwM", "https://www.biospace.com/ochre-bio-closes-9-6m-seed-financing-led-by-khosla-ventures", "https://eithealth.eu/news-article/ochre-bio-closes-e30m-series-a-funding-round/"]}}]]
- source urls
- ["https://eithealth.eu/news-article/ochre-bio-closes-e30m-series-a-funding-round/", "https://hoxtonventures.com/portfolio/ochre-bio/", "https://leadiq.com/c/ochre-bio/5e747adf1d6f06b3824bb58a", "https://rocketreach.co/ochre-bio-management_b437f3e9c1f376e6", "https://tracxn.com/d/companies/ochrebio/__z2z_0KMLRlfkCrZvyOTtgnJ1eFnZwe8OCY_Kbk-RdwM", "https://uk.linkedin.com/company/ochre-bio", "https://www.bioescalator.ox.ac.uk/news-and-events/news/dr-quin-wills-appointed-as-ochre-bio-ceo", "https://www.biospace.com/ochre-bio-closes-9-6m-seed-financing-led-by-khosla-ventures", "https://www.businesswire.com/news/home/20240422784860/en/Ochre-Bio-announces-partnership-with-Boehringer-Ingelheim-to-develop-novel-regenerative-treatments-for-patients-with-advanced-liver-disease", "https://www.businesswire.com/news/home/20240612588243/en/GSK-Enters-Into-a-Multi-Year-Data-Licence-Agreement-With-Ochre-Bio-to-Further-Investigate-the-Drivers-of-Liver-Disease", "https://www.cbinsights.com/company/ochre-bio/financials", "https://www.ochre-bio.com/", "https://www.ochre-bio.com/2024/09/16/ochre-bio-announces-leadership-change/", "https://www.seedtable.com/startups/Ochre_Bio-R9V9YR8", "https://www.ycombinator.com/companies/ochre-bio"]